Handelsavisen
prelaunch
Companies Healthcare FORT.BO
FO
FORT.BO BSE (India) Healthcare Facilities & Services

Fortis Malar Hospitals Ltd

$54,06
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
1 039,3 %
ROE
49,4 %
Net margin
979,5 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Fortis Malar Hospitals Ltd operates in the healthcare sector, providing hospital services and related healthcare facilities, primarily generating revenue through patient care and medical services.

Business. Fortis Malar Hospitals Ltd (FORT.BO) is a healthcare facilities and services company headquartered in India. The firm operates within the Healthcare Services & Equipment sector, providing medical services on a service-revenue basis. It is primarily listed on the Bombay Stock Exchange (BSE). Specific details regarding operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
49,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning FORT.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to FORT.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Fortis Malar Hospitals Ltd (FORT.BO) is a healthcare facilities and services company headquartered in India. The firm operates within the Healthcare Services & Equipment sector, providing medical services on a service-revenue basis. It is primarily listed on the Bombay Stock Exchange (BSE). Specific details regarding operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    Fortis Malar Hospitals Ltd exhibits a strong capital structure, with a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company maintains a high liquidity position, with a current ratio of 17.68, supported by cash and equivalents of INR 1,082.26 million. Despite a negative operating cash flow of INR -73.03 million, the company's substantial cash reserves suggest it is well-positioned to manage short-term liquidity needs.

    In terms of profitability, the company demonstrates a high return on equity (ROE) of 49.37% and a return on assets (ROA) of 46.64%, both significantly above the industry median for healthcare facilities and services. These metrics suggest efficient use of equity and assets to generate profits, aligning with the industry's preferred focus on ROIC and ROA as key performance indicators.

    The company's revenue is concentrated in its core hospital services, with no disclosed segment breakdown. Geographically, the company operates primarily in India, with no material international exposure reported in the latest financial data. This concentration may expose the company to regional economic and regulatory risks, though no immediate geopolitical drivers are flagged in the industry configuration.

    Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The absence of capital expenditure and the low dilution risk suggest a conservative financial strategy, with no immediate plans for expansion or equity issuance. The company's operating income of INR 573.49 million and net income of INR 540.50 million indicate a strong earnings base, which supports the outlook for continued profitability.

    The risk assessment for Fortis Malar Hospitals Ltd indicates a low liquidity risk, supported by its high cash reserves and low debt levels. The company also faces a low dilution risk, with no immediate filing-based flags for equity issuance or share dilution. The absence of significant financial leverage and the conservative capital structure further reduce the company's exposure to credit risk.

    Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's financial statements show consistent performance, with no unusual items or accounting adjustments reported in the latest period. This stability supports the company's current financial outlook and risk profile.

    Key takeaways
    • Fortis Malar Hospitals Ltd maintains a strong capital structure with no long-term debt and a high current ratio.
    • The company's profitability metrics, including ROE and ROA, are significantly above industry medians.
    • The company's revenue is concentrated in its core hospital services, with no material international exposure.
    • The company is projected to maintain a stable revenue trajectory with no significant growth or decline expected.
    • The company faces low liquidity and dilution risks, supported by its high cash reserves and conservative financial strategy.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Fortis Malar Hospitals maintains a debt-to-equity ratio of 0.0, placing it in the top quartile for financial leverage safety.

    The firm exhibits low dilution, liquidity, and credit risks, indicating a stable financial profile with minimal immediate distress signals.

    Best-in-class net margins of 9.80% highlight strong profitability relative to the 4.15% industry median benchmark.

    BEAR CASE · 2

    Cash conversion stands at -0.14, placing the company in the bottom quartile compared to the 1.35 sector median.

    Capex to revenue ratio of -0.42 ranks in the bottom quartile, suggesting potential underinvestment or irregular capital spending patterns.

    In focus — financials by report

    Valuation FY

    Market price
    $54,06
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.09B
    Net cash
    $1.08B
    Current ratio
    17.7
    Debt / equity
    0.0
    ROA
    46.6%
    ROE
    49.4%
    Cash conversion
    -14.0%
    CapEx / revenue
    -41.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin1 039,3 %Best in class
    Net Margin979,5 %Best in class
    ROE49,4 %Best in class
    Capex / Rev-41,7 %Bottom quartile
    D/E0,00Above P75
    Cash Conv-0,14Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Fortis Malar Hospitals Ltd Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    FORT.BOCanonical
    BSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage